[SLN] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- 205.12%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 0 0 0 0 0 8 8 -
PBT -5,370 -4,894 -4,894 1,441 1,441 -3,328 -3,328 37.53%
Tax 507 550 550 508 508 570 570 -7.50%
NP -4,862 -4,344 -4,344 1,949 1,949 -2,758 -2,758 45.88%
Tax Rate - - - -35.30% -35.30% - - -
Total Cost 4,862 4,344 4,344 -1,949 -1,949 2,766 2,766 45.59%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -34,475.00 -34,475.00 -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -0.21 -0.19 -0.19 0.08 0.08 -0.12 -0.12 45.17%
EPS Diluted -0.21 -0.19 -0.19 0.08 0.08 -0.12 -0.12 45.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.